BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 193042)

  • 21. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
    Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
    J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental oncornavirus vaccines in the cat.
    Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
    Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Horizontally and vertically transmitted oncornaviruses of cats.
    Essex M
    Adv Cancer Res; 1975; 21():175-248. PubMed ID: 174397
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis of experimental feline leukemia virus infection.
    Rojko JL; Hoover EA; Mathes LE; Olsen RG; Schaller JP
    J Natl Cancer Inst; 1979 Sep; 63(3):759-68. PubMed ID: 224237
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells.
    Snyder HW; Hardy WD; Zuckerman EE; Fleissner E
    Nature; 1978 Oct; 275(5681):656-8. PubMed ID: 212681
    [No Abstract]   [Full Text] [Related]  

  • 26. Mammalian C-type oncornaviruses: relationships between viral structural and cell-surface antigens and their possible significance in immunological defense mechanisms.
    Schäfer W; Bolognesi DP
    Contemp Top Immunobiol; 1977; 6():127-67. PubMed ID: 68853
    [No Abstract]   [Full Text] [Related]  

  • 27. [Feline leukosis and sarcoma viruses].
    Merekalova ZI
    Vopr Virusol; 1976; (4):390-9. PubMed ID: 64021
    [No Abstract]   [Full Text] [Related]  

  • 28. Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated.
    Fischinger PJ; Ihle JN; Bolognesi DP; Schäfer W
    Virology; 1976 May; 71(1):346-51. PubMed ID: 179206
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological studies of tumors induced in sheep by injecting ovine cells transformed in vitro with feline sarcoma virus.
    Theilen GH; Pedersen NC; Hall JG
    Bibl Haematol; 1975 Oct; (43):380-3. PubMed ID: 183703
    [No Abstract]   [Full Text] [Related]  

  • 30. Surface properties of mammalian C type viruses.
    Maruyama K; Miller MF; Hixson DC; Wagner SH
    Bibl Haematol; 1975 Oct; (43):425-9. PubMed ID: 183712
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody.
    Grant CK; Harris D; Essex ME; Pickard DK; Hardy WD; de Noronha F
    J Natl Cancer Inst; 1980 Jun; 64(6):1527-33. PubMed ID: 6246303
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of viruses in the etiology of naturally occurring feline leukemia.
    Essex M; Grant CK; Cotter SM; Hardy WD
    Haematol Blood Transfus; 1981; 26():483-7. PubMed ID: 6274762
    [No Abstract]   [Full Text] [Related]  

  • 33. Infection and immunization of cats with the Kawakami-Theilen strain of feline leukemia virus.
    Salerno RA; Larson VM; Phelps AH; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Jan; 160(1):18-23. PubMed ID: 217021
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human serum lyses RNA tumour viruses.
    Welsh RM; Cooper NR; Jensen FC; Oldstone MB
    Nature; 1975 Oct; 257(5527):612-4. PubMed ID: 170540
    [No Abstract]   [Full Text] [Related]  

  • 36. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
    Salerno RA; Lehman ED; Larson VM; Hilleman MR
    J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605
    [No Abstract]   [Full Text] [Related]  

  • 37. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
    Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
    J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a subunit feline leukemia virus vaccine in exotic cats.
    Citino SB
    J Am Vet Med Assoc; 1988 Apr; 192(7):957-9. PubMed ID: 2835347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
    Essex M; Cotter SM; Hardy WD; Hess P; Jarrett W; Jarrett O; Mackey L; Laird H; Perryman L; Olsen RG; Yohn DS
    J Natl Cancer Inst; 1975 Aug; 55(2):463-7. PubMed ID: 169377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.